Atlas Trials

The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom

Clinical trial NCT06373913 · RECRUITING

Trial details

NCT number
NCT06373913
Sponsor
Kolding Sygehus
Status
RECRUITING
Study type
OBSERVATIONAL
HyperlipidemiasNephrotic Syndrome
Start date
2023-06-01
Primary completion
2027-07-30
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.